SAR 4.08
(0.25%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 17.34 Million | 25.48 Million | 15.65 Million | -17.43 Million | 8.02 Million | 54.85 Million |
Net Income | -11.47 Million | 13.68 Million | -133.12 Million | -66.24 Million | 27.97 Million | 21.07 Million |
Depreciation & Amortization | 23.41 Million | 29.89 Million | 30.59 Million | 30.98 Million | 34.55 Million | 5.94 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -6.73 Million | -18.59 Million | -17.4 Million | -57.15 Million | -62.44 Million | 15.71 Million |
Other non-cash items | 71.63 Million | 485.3 Thousand | 135.57 Million | 74.96 Million | 7.93 Million | 12.12 Million |
Investing Cash Flow | - | 43.64 Million | -26.73 Million | -223.72 Thousand | 121.15 Million | -729.61 Million |
Investments in PPE | -3.00 | -2.47 Million | -3.91 Million | - | -434.46 Thousand | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | -729.61 Million |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | 46.12 Million | -22.82 Million | -223.72 Thousand | 121.59 Million | - |
Financing Cash Flow | -12.25 Million | -23.49 Million | -19.72 Million | 20.68 Million | -10.48 Million | 679.5 Million |
Debt repayment | - | -12.49 Million | -10.29 Million | -5.9 Million | -10.3 Million | -274.93 Million |
Dividends payments | - | -10.99 Million | -14.63 Million | -18.31 Million | -27.56 Million | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | 404.56 Million |
Other Financing Activities | -12.25 Million | 13.34 Million | 5.2 Million | 44.9 Million | 27.38 Million | 274.93 Million |
Accounts receivables | -7.47 Million | -3.49 Million | -16.61 Million | -15.93 Million | -13.16 Million | -38.71 Million |
Accounts payables | -5.2 Million | -17.73 Million | -9 Million | -19.81 Million | -30 Million | 59.75 Million |
Inventory | - | - | - | 16.75 Million | 1.4 Million | - |
Other working capital | 5.93 Million | 2.63 Million | 8.21 Million | -38.15 Million | -20.68 Million | -1.09 Million |
Cash at beginning of period | 3.22 Million | 1.22 Million | 5.3 Million | 2.28 Million | 4.74 Million | -674.76 Million |
Cash at end of period | 8.31 Million | 3.22 Million | 1.22 Million | 5.3 Million | 2.28 Million | 4.74 Million |
Capital Expenditure | -3.00 | -2.47 Million | -3.91 Million | - | -434.46 Thousand | - |
Effect of forex changes on cash | - | -43.64 Million | 26.73 Million | - | -121.15 Million | 674.76 Million |
Net cash flow / Change in cash | 5.09 Million | 1.99 Million | -4.07 Million | 3.01 Million | -2.45 Million | 679.5 Million |
Free Cash Flow | 17.34 Million | 23 Million | 11.73 Million | -17.43 Million | 7.59 Million | 54.85 Million |
Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 1.46 Million | -24.45 Million | -11.47 Million | 6490.07 | 6490.07 | 13.68 Million |
Depreciation & Amortization | 11.63 Million | 8.46 Million | 23.41 Million | 7474.94 | 7474.94 | 29.89 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -2.17 Million | 356.53 Thousand | -6.73 Million | -3377.39 | -3377.39 | -18.59 Million |
Other non-cash items | 25.94 Million | 43.86 Million | 71.63 Million | 643.80 | 643.80 | 485.3 Thousand |
Investing Cash Flow | - | - | - | - | - | 43.64 Million |
Investments in PPE | - | - | - | - | - | -2.47 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | 46.12 Million |
Financing Cash Flow | -11.61 Million | -4.75 Million | -12.25 Million | -10.12 Thousand | -10.12 Thousand | -23.49 Million |
Debt repayment | - | - | - | - | - | -12.49 Million |
Dividends payments | -5.86 Million | - | - | - | - | -10.99 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -1 Million | - | - | -10.12 Thousand | -10.12 Thousand | 13.34 Million |
Accounts receivables | -5.99 Million | -679.53 Thousand | -7.47 Million | -2529.20 | -2529.20 | -3.49 Million |
Accounts payables | - | -3 Million | -5.2 Million | -2.2 Million | - | -17.73 Million |
Inventory | - | - | - | - | - | - |
Other working capital | 3.82 Million | 4.03 Million | 5.93 Million | -848.19 | -848.19 | 2.63 Million |
Cash at beginning of period | 8.31 Million | 5.43 Million | 3.22 Million | 3.22 Million | - | 1.22 Million |
Cash at end of period | 4.3 Million | 8.31 Million | 8.31 Million | 5.43 Million | 1107.74 | 3.22 Million |
Capital Expenditure | - | - | - | - | - | -2.47 Million |
Effect of forex changes on cash | - | - | - | - | - | -43.64 Million |
Net cash flow / Change in cash | -4 Million | 2.87 Million | 5.09 Million | 2.21 Million | 1107.74 | 1.99 Million |
Free Cash Flow | 7.6 Million | 7.62 Million | 17.34 Million | 11.23 Thousand | 11.23 Thousand | 23 Million |
CDVIQ
ZAPLOX
HUN
3161
8379
AKT-A